Parkinsonism & Related Disorders
Volume 15, Issue 1 , Pages 24-29 , January 2009

Vascular pathology in patients with idiopathic Parkinson's disease

Received 14 May 2007 ,Revised 30 January 2008 ,Accepted 12 February 2008.

References 

  1. Roos RAC, Jongen JCF, van der Velde EA. Clinical course of patients with idiopathic Parkinson's disease. Mov Disord. 1996;11(3):236–242
  2. Burton EJ, McKeith IG, Burn DJ, Wiliams DE, O'rien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain. 2004;127:791–800
  3. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–184
  4. Jellinger KA. The neuropathologic diagnosis of secondary parkinsonian syndromes. In:  Battistin L,  Scarlato G,  Caraceni T,  Ruggieri S editor. Advances in neurology. vol. 69:New York: Raven Press; 1996;p. 293–303
  5. Jellinger KA. Overview of morphological changes in Parkinson's disease. In:  Yahr MD,  Bergmann KJ editor. Advances in neurology. vol. 45:New York: Raven Press; 1986;p. 1–18
  6. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999;56:98
  7. Rektor I, Rektorová I, Kubová D. Vascular parkinsonism – an update. J Neurol Sci. 2006;248:185–191
  8. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51:745–752
  9. Fahn S, Elston RL, members of the UPDRS Development Committee . Unified Parkinson's disease rating scale. In:  Fahn S,  Marsden CD,  Goldstein M,  Calne DB editor. Recent developments in Parkinson's disease. vol. 2:New York: Macmillan; 1987;p. 153–163
  10. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442
  11. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186
  12. Mahoney FI, Barthel DW. Functional evaluation: the BARTHEL index. Md State Med J. 1965;14:61–65
  13. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  14. Benton AL. Contributions to neuropsychological assessment. New York, NY: Oxford University Press Inc.; 1983;
  15. Solomon PR, Hirschoff A, Kelly B, Relin M, Brush M, DeVeaux RD, et al. A 7 minute neurocognitive screening battery highly sensitive to AD. Arch Neurol. 1998;55:349–355
  16. Freedman M, Kaplan E, Delis D, Morris R. Clock drawing: a neuropsychological analysis. New York: Oxford University Press; 1994;
  17. Nussbaum PD, Fields RB, Starrat C. Comparison of three scoring procedures for the clock drawing. J Clin Exp Neuropsychol. 1992;4:44
  18. Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn. 1992;18:70–87
  19. Hendriksen Ch, Meier D, v. Klitzing W, Krebs M, Ermini-Funfschilling D, Stahelin HB. Early dementia and the clock drawing test. Memory Clinic. Geriatric University Clinic Basel, Switzerland: Internal Press; 1993;
  20. Auriacombe S, Grossman M, Carvell S, Gollomp S. Verbal fluency deficits in Parkinson's disease. Neuropsychology. 1993;7:182–192
  21. Bayles KA, Trosset MW, Tomoeda CK, Montgomery EB. Generative naming in Parkinson's disease. J Clin Exp Neuropsychol. 1993;15:547–562
  22. Wechsler D. Wechsler memory scale – third edition, WMS-III. San Antonio, Texas: The Psychological Corporation; 1997;
  23. Barr A, Brandt J. Word-list generation deficits in dementia. J Clin Exp Neuropsychol. 1996;18:810–822
  24. Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FV. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry. Jul 2000;15(7):644–649
  25. Montgomery SA, Asberg MA. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1975;134:382–389
  26. Cupini LM, Pasqualetti P, Diomedi M, Vernieri F, Silvestrini M, Rizzato B, et al. Ultrasound diagnosis of cerebrovascular disease. Stuttgart: Georg Thieme Verlag; 1993;
  27. Baldassarre D, Amato M, Bondioli A, Sirtori CR, Tremoli E. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke. 2000;31:2426–2430
  28. Frauchiger B, Schmid HP, Roedel Ch, Moosmann P, Staub D. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke. 2001;32:836–841
  29. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14–22
  30. Lee KY, Sohn YH, Baik JS, Kim GW, Kim J-S. Arterial pulsatility as an index of cerebral microangiopathy in diabetes. Stroke. 2000;31:1111–1115
  31. Prins ND, van Dijk EJ, den Heijer T, Veremeer SE, Koudstaal PJ, Oudkerk M, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61:1531–1534
  32. Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starksteiner SE. Cognitive functions in major depression and Parkinson's disease. Arch Neurol. 1997;54:982–986
  33. Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol. 1995;52:1164–1169
  34. Levine RL, Jones JC, Bee N. Stroke and Parkinson's disease. Stroke. 1992;23:839–842
  35. Antonini A, Barone P, Abbruzzese G, Bonuccelli U, Righini SA, Vado S. How vascular disease affects parkinsonism. The VADO study. Mov Disord. 2006;21(Suppl. 15):S533
  36. Inzelberg R, Bornstein NM, Reider I, Korczyn AD. Basal ganglia lacunes and parkinsonism. Neuroepidemiology. 1994;13:108–112
  37. Visser M, Marinus J, van Hilten JJ, Schipper RGB, Stiggelbout AM. Assessing comorbidity in patients with parkinson's disease. Mov Disord. 2004;17(7):824–828
  38. Jonhston CS, O'Meara ES, Manolio TA, Lefkowitz D, O'Leary DH, Goldstein S, et al. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med. 2004;140:237–247
  39. Elbaz A, Ripert M, Tavernier B, Fevrier B, Zureik M, Gariepy J, et al. Common carotid artery intima-media thickness, carotid plaques, and walking speed. Stroke. 2005;36(10):2198–2202
  40. Haugarvoll K, Aarsland D, Larsen JP. The role of cerebrovascular risk factors for dementia in Parkinson's disease. Mov Disord. 2004;19(Suppl. 9):403–404
  41. Aarsland D, Anderson K, Larsen JP, Perry R, Wentzel-Larsen T, Lolk A, et al. The rate of cognitive decline in Parkinson disease. Arch Neurol. 2004;61:1906–1911
  42. Vingerhoets G, Verdelen S, Santens P, Miatton M, De Reuck J. Predictors of cognitive impairment in advanced Parkinson's disease. J Neurol Neurosurg Psychiatry. 2003;74:793–796
  43. Sawada H, Udaka F, Kameyama M, Seriu N, Nishinaka K, Shindou K, et al. SPECT finding in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry. 1992;55:960–963
  44. Korczyn AD. The underdiagnosis of vascular contribution to dementia. J Neurol Sci. 2005;229–230:3–6

PII: S1353-8020(08)00089-8

doi: 10.1016/j.parkreldis.2008.02.007

Parkinsonism & Related Disorders
Volume 15, Issue 1 , Pages 24-29 , January 2009

Article Tools